Revercomb Lucy, Hanmandlu Ankit, Wareing Nancy, Akkanti Bindu, Karmouty-Quintana Harry
Department of BioSciences, Rice University, Houston, TX, United States.
Department of Biochemistry and Molecular Biology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, United States.
Front Mol Biosci. 2021 Jan 18;7:624093. doi: 10.3389/fmolb.2020.624093. eCollection 2020.
Acute respiratory distress syndrome (ARDS) is a severe and often fatal disease. The causes that lead to ARDS are multiple and include inhalation of salt water, smoke particles, or as a result of damage caused by respiratory viruses. ARDS can also arise due to systemic complications such as blood transfusions, sepsis, or pancreatitis. Unfortunately, despite a high mortality rate of 40%, there are limited treatment options available for ARDS outside of last resort options such as mechanical ventilation and extracorporeal support strategies. A complication of ARDS is the development of pulmonary hypertension (PH); however, the mechanisms that lead to PH in ARDS are not fully understood. In this review, we summarize the known mechanisms that promote PH in ARDS. (1) Provide an overview of acute respiratory distress syndrome; (2) delineate the mechanisms that contribute to the development of PH in ARDS; (3) address the implications of PH in the setting of coronavirus disease 2019 (COVID-19).
急性呼吸窘迫综合征(ARDS)是一种严重且往往致命的疾病。导致ARDS的原因多种多样,包括吸入盐水、烟雾颗粒,或由呼吸道病毒造成的损伤。ARDS也可能因全身并发症而出现,如输血、败血症或胰腺炎。不幸的是,尽管ARDS的死亡率高达40%,但除了机械通气和体外支持策略等最后手段外,针对ARDS的治疗选择有限。ARDS的一个并发症是肺动脉高压(PH)的发展;然而,导致ARDS中PH的机制尚未完全明确。在本综述中,我们总结了已知的促进ARDS中PH的机制。(1)概述急性呼吸窘迫综合征;(2)阐述导致ARDS中PH发展的机制;(3)探讨PH在2019冠状病毒病(COVID-19)背景下的影响。